HealthLeaders Media May 4, 2022
Scott Mace

Vital signs sticker aims to detect early signs of trouble, including infection, in bone marrow transplant recipients.

KEY TAKEAWAYS

Predictive analytics, portable imaging, and telemedicine round out technology utilization.

Study compensates to recognize that typical body temperature can vary from patient to patient.

Trial will start in Denver metro area, but ultimately could lead to regional remote monitoring services.

A Colorado health system is testing the feasibility of remote patient monitoring for the early detection of febrile neutropenia, a common, life-threatening complication of cancer therapy that is typically treated as an oncologic emergency.

Ten bone-marrow transplant recipients will initially participate in the trial at the University of Colorado Anschutz Medical Campus, also known as CU Anschutz. The phased approach, through...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Biotechnology, Clinical Trials, Digital Health, Health IT, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Telehealth, Trends
Where do Psychedelics Fit in the Future of Psychiatry?
2024: record year for AI trials
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape

Share This Article